Based on our previous work on inferior DRFS in Black patient with residual ER+/HER2- breast cancer, compared to white patients30, we only included Black and white patients in current study to investigate the biology of the racial disparity in these patient groups. This evidence concerns the gene ERBB2 and breast carcinoma.